SCHEMBL9749683

SCHEMBL9749683

CS(=O)(=O)NS(=O)(=O)c1cc(N)ccc1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.43
▸ RAPGEF4 Q8WZA2 1/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ RECQL P46063 3/20 0.40
▸ KDM4E B2RXH2 2/20 0.40
▸ POLB P06746 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ CASP6 P55212 2/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ ELAVL1 Q15717 1/20 0.40
▸ CYP3A4 P08684 1/20 0.39
▸ THRB P10828 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9748282 0.78 CYP3A4 (0.49) L3MBTL1ALDH1A1GAATDP1MEN1
SCHEMBL9175606 0.78 L3MBTL1 (0.61) L3MBTL1RAPGEF4ALDH1A1RECQLKDM4E
SCHEMBL390918 0.77 L3MBTL1 (0.40) L3MBTL1RAPGEF4ALDH1A1RECQLKDM4E
SCHEMBL9750234 0.77 L3MBTL1 (0.39) L3MBTL1RAPGEF4ALDH1A1RECQLKDM4E
SCHEMBL6622707 0.77 GAA (0.54) GAATDP1MEN1KMT2ANSD2
SCHEMBL390917 0.76 ALDH1A1 (0.48) L3MBTL1RAPGEF4ALDH1A1RECQLKDM4E
SCHEMBL17774567 0.75 CYP3A4 (0.40) L3MBTL1RAPGEF4ALDH1A1RECQLKDM4E
SCHEMBL9294471 0.73 CDC25B (0.55) L3MBTL1RAPGEF4ALDH1A1RECQLKDM4E
SCHEMBL4250009 0.72 CA1 (0.57) ALDH1A1TDP1MEN1KMT2ACYP3A4
SCHEMBL393315 0.71 CA2 (0.54) L3MBTL1ALDH1A1RECQLKDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9872822-B2 Process for dyeing in the presence of oxidation bases comprising at least one sulfonic, sulfonamide, sulfone, amid or acid group and a metal catalyst, device and ready-to-use composition L'OREAL (FR) 2018-01-23 — — US disclosed
US-20160143826-A1 PROCESS FOR DYEING IN THE PRESENCE OF OXIDATION BASES COMPRISING AT LEAST ONE SULFONIC, SULFONAMIDE, SULFONE, AMID OR ACID GROUP AND A METAL CATALYST, DEVICE AND READY-TO-USE COMPOSITION L'OREAL (FR) 2016-05-26 — — US disclosed
US-20160143826-A1 PROCESS FOR DYEING IN THE PRESENCE OF OXIDATION BASES COMPRISING AT LEAST ONE SULFONIC, SULFONAMIDE, SULFONE, AMID OR ACID GROUP AND A METAL CATALYST, DEVICE AND READY-TO-USE COMPOSITION L'OREAL (FR) 2016-05-26 — — US disclosed
EP-0205079-B1 ACID DISULFIMIDE TRIPHENODIOXAZINE DYES BAYER AG (DE) 1992-01-22 — — EP disclosed
EP-0205079-A2 Acid disulfimide triphenodioxazine dyes BAYER AG (DE) 1986-12-17 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160143826-A1 PROCESS FOR DYEING IN THE PRESENCE OF OXIDATION BASES COMPRISING AT LEAST ONE SULFONIC, SULFONAMIDE, SULFONE, AMID OR ACID GROUP AND A METAL CATALYST, DEVICE AND READY-TO-USE COMPOSITION KRT18, ARSA, SQOR L3MBTL1 4874/4885RAPGEF4 4858/4885ALDH1A1 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback